Joubert syndrome 14 is a rare genetic condition that affects brain development and coordination. People with Joubert syndrome 14 often have low muscle tone, breathing pattern changes, balance problems, and delayed milestones. Signs usually start in infancy and can be lifelong, but not everyone will have the same experience. Care focuses on therapies, breathing support if needed, seizure control when present, and monitoring of eyes and kidneys. The outlook varies, and many living with Joubert syndrome 14 do well with supportive care and regular follow-up.
Overview
Joubert syndrome 14Symptoms
Early signs of Joubert syndrome 14 include floppy muscle tone, irregular breathing in babies, jerky eye movements, and delayed sitting or walking. Later, many have poor balance, clumsy gait, and learning or speech delays. Features vary in severity.
Outlook and prognosis
Many living with Joubert syndrome 14 grow and learn at their own pace, with wide variation in abilities. Early therapies, vision support, and seizure control can improve daily function and independence. Ongoing care helps manage breathing spells, movement challenges, and learning needs over time.
Causes and risk factors
Joubert syndrome 14 results from inheriting two faulty copies of a gene affecting cilia function (autosomal recessive), usually from carrier parents. Risk rises with family history or parental relatedness; environment and lifestyle don’t cause it but can modify complications.
Genetic influences
Genetics are central to Joubert syndrome 14. It is typically caused by inherited changes in the TTC21B gene, affecting cilia function. Most cases follow an autosomal recessive pattern; carrier testing and genetic counseling can guide family planning and recurrence risk.
Diagnosis
Doctors suspect Joubert syndrome 14 from clinical features and a characteristic molar tooth pattern on brain MRI. Genetic testing confirms the diagnosis and pinpoints the subtype; many centers call this the genetic diagnosis of Joubert syndrome 14.
Treatment and drugs
Treatment for Joubert syndrome 14 focuses on what matters day to day: breathing support in infancy, therapies to build motor and speech skills, and targeted help for vision and balance. Doctors may use seizure medicines, kidney and liver monitoring, and tailored educational supports. Regular check-ins guide adjustments as needs change.
Symptoms
Many families first notice a very floppy baby who tires easily, breathes in an irregular pattern, or struggles with feeding. As children grow, delays in sitting, walking, and speech, along with clumsy or wide‑based walking and unusual eye movements, become clearer. These are common early features of Joubert syndrome 14, which affects brain areas that coordinate movement and eye control. Features vary from person to person and can change over time.
Babies may feel limp when held and have trouble holding up their head. This low tone can make feeding and later sitting or walking take longer.
Rolling, sitting, and walking often happen later than expected. This is common in Joubert syndrome 14 and usually benefits from early physical and occupational therapy.
In medical terms, this is ataxia; in everyday life, it shows up as unsteady steps and difficulty with precise hand work. A wide-based walk and frequent falls are common.
Eyes may not jump quickly to a new target or may shake. This can make reading lines of text or following moving objects harder.
How people usually first notice Joubert syndrome 14?
Many families first notice something is different in the first months of life: a very floppy feel to the baby (low muscle tone), slow or wobbly head control, unusual breathing patterns that can be fast or pause-like, and eye movements that don’t track smoothly. Doctors often pick up the “first signs of Joubert syndrome 14” during infancy when developmental milestones are delayed, or on brain imaging ordered for low tone or breathing/eye movement concerns, which can show the characteristic “molar tooth” appearance in the midbrain. Some children are identified even earlier if prenatal ultrasound or MRI raises concern about brain development, leading to newborn checks that confirm how Joubert syndrome 14 is first noticed.
Types of Joubert syndrome 14
Joubert syndrome 14 is one form within the broader Joubert syndrome spectrum, which has multiple genetic variants that can look similar but differ in severity and organ involvement. In medical terms, these are called clinical or genetic subtypes, defined by the underlying gene change. People may notice different sets of symptoms depending on their situation.
TMEM237-related core
This variant often causes the classic Joubert features—low muscle tone, delayed milestones, and the characteristic brain finding on MRI. Vision tracking and balance can be more affected early on.
Ocular involvement
Some with this variant develop eye movement problems, nystagmus, or retinal changes that can reduce night or peripheral vision. Regular eye exams help track changes and guide low-vision supports.
Kidney involvement
A subset develops kidney cysts or scarring over time, which may first show up as high blood pressure or changes in urine tests. Blood and urine monitoring supports early detection and treatment.
Liver involvement
Less commonly, scarring in the liver can occur, sometimes leading to enlarged spleen or abnormal blood tests. Ultrasound and labs can spot early shifts before symptoms become obvious.
Neurologic severity range
Movement coordination, breathing rhythm, and developmental delays vary from mild to more pronounced. The balance of symptoms can shift over time.
What genetics can tell you about symptoms
In Joubert syndrome 14, changes in the TMEM237 gene disrupt cilia, tiny cell “antennae,” leading to the molar tooth sign on brain MRI, low muscle tone, poor balance, and delayed milestones. Some also have abnormal eye movements, breathing rhythm problems, and kidney or liver issues.
Causes and risk factors
Joubert syndrome 14 is caused by inherited changes in a cilia‑related gene, usually in an autosomal recessive pattern. The main risk is having parents who both carry the same gene change, and risk is higher when parents are related. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Infections, nutrition, and access to therapies can influence day‑to‑day function, and genes largely shape the early symptoms of Joubert syndrome 14. Genetic counseling and testing can help clarify carrier status and future pregnancy risks.
Environmental and biological risk factors
People planning a pregnancy or already pregnant sometimes wonder what in their body or surroundings could raise the chance of Joubert syndrome 14. Doctors often group risks into internal (biological) and external (environmental). For this condition, research to date has not found clear environmental or pregnancy-related factors that reliably increase the chance. People may still hear about early symptoms of Joubert syndrome 14 after birth, but before birth, no specific environmental triggers have been confirmed.
Current studies have not shown that common environmental pollutants or toxins raise the chance of Joubert syndrome 14. No exposure has been confirmed as a cause.
Infections during pregnancy can affect fetal development in general, but they have not been tied specifically to a higher risk of Joubert syndrome 14. Routine prevention and treatment remain important for overall pregnancy health.
Older maternal or paternal age increases the chance of some conditions, but has not been shown to increase the likelihood of Joubert syndrome 14. Available data do not support an age-related effect for this subtype.
Health issues like diabetes or thyroid disease can influence pregnancy, yet there is no clear evidence they increase the chance of Joubert syndrome 14. Managing these conditions supports general fetal health.
Genetic risk factors
Joubert syndrome 14 is driven by harmful changes in the TMEM237 gene, which helps cells build and run the primary cilium. Some risk factors are inherited through our genes. The genetic causes of Joubert syndrome 14 follow an autosomal recessive pattern, meaning a child must inherit two nonworking copies, one from each parent. Genetic testing can confirm the cause and clarify risks for siblings and future pregnancies.
TMEM237 gene: Harmful changes in TMEM237 are the known genetic cause of Joubert syndrome 14. This gene helps cells form and control the primary cilium, a structure important for development. Testing focuses on finding disease-causing changes in this specific gene.
Autosomal recessive: A child is affected when two nonworking copies of TMEM237 are inherited, one from each parent. If both parents are carriers, each pregnancy has a 1 in 4 (25%) chance to have Joubert syndrome 14.
Carrier parents: Parents typically have no symptoms but each carries one TMEM237 change. Two carriers together can have children with Joubert syndrome 14, and their relatives may also be carriers.
Consanguinity: When parents are biologically related, they are more likely to carry the same TMEM237 change. This increases the chance of a child being born with Joubert syndrome 14.
Variant types: Disease-causing changes can either stop TMEM237 from working or alter how the protein folds and functions. Some people with Joubert syndrome 14 have missing or extra pieces in this gene, so labs often check for both small changes and larger deletions or duplications.
Homozygous or compound: People with Joubert syndrome 14 may have the same change on both copies of TMEM237 or two different changes. Either pattern disrupts the gene enough to cause the condition.
Variable expression: Features can differ even among siblings with the same TMEM237 changes. This helps explain why early symptoms of Joubert syndrome 14 may not look identical from child to child.
Genetic testing: A Joubert gene panel or exome/genome test can confirm TMEM237 involvement in Joubert syndrome 14. Results guide carrier testing for family members and refine recurrence risks.
Recurrence risk: Once TMEM237 changes are identified in a family, future pregnancies can be tested if parents wish. Options may include prenatal or preimplantation testing after genetic counseling.
Lifestyle risk factors
Joubert syndrome 14 is a congenital condition; lifestyle habits do not cause it, but they can shape how symptoms are managed and how complications develop. Understanding how lifestyle affects Joubert syndrome 14 helps families choose daily routines that support motor skills, breathing patterns, and learning. The elements below link day-to-day choices to specific aspects of the condition.
Regular, therapist-guided exercises can improve hypotonia, balance, and coordination. Consistency may reduce falls and help children reach motor milestones sooner.
Low-impact activities like swimming or cycling can build endurance without overwhelming ataxic balance. Avoiding high-risk contact sports may lower injury risk from coordination challenges.
A steady sleep schedule may smooth breathing irregularities seen during drowsiness and sleep. Better sleep can improve daytime attention, therapy participation, and mood.
Texture-modified foods and slow, upright feeding can lower choking and aspiration risk from oromotor incoordination. Small, frequent meals may support growth when fatigue limits intake.
Risk prevention
Joubert syndrome 14 is a genetic condition, so we can’t fully prevent it, but there are steps to lower the chance of passing it on and to prevent complications. Prevention is about lowering risk, not eliminating it completely. Planning before pregnancy and early, coordinated care after birth both make a meaningful difference. For those already living with it, the focus is avoiding triggers, catching problems early, and supporting steady development.
A genetics professional can explain inheritance and personal risks. They can discuss options that fit your values and plans.
Blood or saliva tests can check if you and your partner carry the gene change. If both carry it, the chance of an affected child is higher.
Chorionic villus sampling or amniocentesis can test a pregnancy if the family’s variant is known. Detailed fetal imaging may look for brain features linked to Joubert syndrome.
In vitro fertilization with embryo genetic testing can lower the chance of passing on the condition. This option may be considered if both partners are carriers.
Transmission
Joubert syndrome 14 is not contagious; it cannot be passed between people through everyday contact. It is an inherited condition, usually following an autosomal recessive pattern, meaning a child must receive two nonworking copies of the gene—one from each parent who are typically healthy carriers.
When both partners are carriers, each pregnancy has a 25% chance of a child with Joubert syndrome 14, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither change. Rarely, one of the two gene changes can occur for the first time in a child, but the pattern of how Joubert syndrome 14 is inherited remains the same; a genetics professional can explain the genetic transmission of Joubert syndrome 14 and testing options for family members.
When to test your genes
Joubert syndrome 14 is genetic, so testing is most useful when there’s a family history, a prior affected child, or suggestive prenatal/early-life brain findings (e.g., “molar tooth sign”) to confirm diagnosis and guide care. Parents considering pregnancy may seek carrier or prenatal testing. Genetic results can tailor surveillance for breathing, vision, kidneys, and development.
Diagnosis
Joubert syndrome 14 is often suspected when a baby has low muscle tone, unusual breathing patterns, and developmental delays, and a brain scan shows a characteristic look. Doctors then use a combination of exams and tests to confirm the cause and understand which body systems are involved. These findings guide the genetic diagnosis of Joubert syndrome 14. Early and accurate diagnosis can help you plan ahead with confidence.
A pediatric neurologic exam looks for low muscle tone, balance issues, and coordination problems. A detailed family and health history can help connect early symptoms with this pattern.
Radiologists look for the “molar tooth sign,” a specific shape in the midbrain and cerebellum. Seeing this pattern strongly supports Joubert syndrome 14 and helps distinguish it from other conditions.
An eye exam checks for tracking difficulties, light sensitivity, or signs of retinal change. These findings can support the diagnosis of Joubert syndrome 14 and inform monitoring plans.
Clinicians observe breathing patterns in infants, which may be fast, slow, or irregular. They also assess balance and coordination as children grow, since these features are common in Joubert syndrome 14.
Stages of Joubert syndrome 14
Joubert syndrome 14 does not have defined progression stages. It’s a genetic condition present from birth, and while development and health needs can change over time, they don’t follow a predictable step-by-step pattern. Early symptoms of Joubert syndrome 14 may include low muscle tone, unusual breathing patterns, trouble with eye tracking, and delayed motor milestones; doctors often combine a detailed exam with brain MRI to look for the “molar tooth” sign that supports the diagnosis. Different tests may be suggested to help confirm the diagnosis and check for related eye, kidney, or liver involvement, and genetic testing can identify the specific subtype and guide monitoring over time.
Outlook and prognosis
Looking ahead can feel daunting, but many living with Joubert syndrome 14 build stable routines that support school, work, and family life. Early care can make a real difference, especially for breathing control in infancy, feeding and growth, vision and balance, and developmental skills. Some people experience mild coordination issues and learning differences, while others notice more significant motor delays or kidney and liver involvement later in childhood or adolescence. When doctors talk about “remission,” they mean symptoms have eased or disappeared for a while, but with Joubert syndrome 14 most features tend to persist and are managed over time rather than fully going away.
Understanding the prognosis can guide planning and help set realistic goals for therapies and education. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including how early therapies start and how consistently kidney, liver, and eye health are monitored. Serious complications are most likely when organs such as the kidneys or liver become involved; this can affect life expectancy if not detected and treated promptly. For many, this can mean regular checkups, hearing and vision assessments, and kidney and liver tests to catch changes before they cause symptoms.
The outlook is not the same for everyone, but many people with Joubert syndrome 14 reach adulthood, and mortality is highest in infancy when severe breathing problems or major organ issues occur. Over time, most people gain skills, though progress may be uneven; early symptoms of Joubert syndrome 14 like low muscle tone and poor balance often improve with physical and occupational therapy. Support from friends and family can strengthen adherence to routines, therapy, and appointments, which helps preserve function and independence. Talk with your doctor about what your personal outlook might look like, including what to watch for and how your plan may evolve as new treatments and supports become available.
Long-term effects
Daily life with Joubert syndrome 14 can be shaped by movement, learning, and vision differences that continue from childhood into adulthood. Long-term effects vary widely, and not everyone will experience the same set or severity of features. Early symptoms of Joubert syndrome 14 often include irregular breathing and weak muscle tone in infancy, which can shift over time into longer-term motor and learning challenges. Outlook often depends on whether the eyes, kidneys, or liver are involved, since these organs can influence health over the years.
Ongoing balance and coordination challenges can affect walking speed, stamina, and confidence on uneven ground. Many continue to improve skills over time, but some level of ataxia often remains.
Speech may be delayed and remain somewhat unclear, with short phrases easier than long sentences. Many people with Joubert syndrome 14 communicate well using a mix of speech, gestures, or devices.
Thinking and learning skills range from near-typical to moderate impairment. School and work tasks that require planning, quick shifts, or fine motor skills may be harder.
Difficulty with fast eye movements can make tracking words or moving objects tiring. Some develop retinal degeneration, which can reduce night vision and may slowly narrow the visual field.
How is it to live with Joubert syndrome 14?
Living with Joubert syndrome 14 often means pacing life around fatigue, balance challenges, and slower processing on busy days, while celebrating steady gains from therapies. Many find that visual tracking, coordination, and speech can improve with early supports, but crowds, bright lights, or sudden changes in routine may still be draining. Families, classmates, and caregivers often become skilled collaborators—using clear schedules, extra time for tasks, and mobility or communication aids—to help daily routines run smoothly. With patience, regular therapies, and a team that knows the person’s strengths, school, work, and social life can be adapted in ways that feel both achievable and meaningful.
Treatment and drugs
Treatment for Joubert syndrome 14 focuses on easing symptoms, supporting development, and preventing complications, since there’s no single cure. Care usually involves a coordinated team: early physical, occupational, and speech therapy to build skills; vision and hearing support; and educational plans tailored to the child’s needs. Doctors monitor breathing patterns, sleep, kidney and liver health, growth, and eye findings, and may use medicines to manage issues like abnormal breathing, seizures, reflux, or mood and attention challenges. Supportive care can make a real difference in how you feel day to day. In select situations, surgery may help with related problems (for example, significant vision issues or organ complications), and genetic counseling can guide family planning and connect families with research or clinical trials.
Non-drug treatment
Day-to-day care for Joubert syndrome 14 focuses on strengthening movement, communication, and independence at home and school. Beyond prescriptions, supportive therapies can help children build skills and reduce complications over time. Early symptoms of Joubert syndrome 14 may include low muscle tone, unusual eye movements, and breathing changes, so non-drug care often starts early and adapts as needs change.
Targeted exercises build strength, balance, and coordination. Therapists teach safe ways to move, sit, and transfer to reduce falls.
Daily-living skills—dressing, feeding, handwriting—are broken into manageable steps. Adaptive tools and home tweaks make tasks safer and easier.
Speech therapy supports sounds, words, and understanding. Feeding therapy improves chewing, swallowing, and reduces choking risk.
Picture boards or speech-generating devices help express needs. Therapists match the tool to the child’s abilities and update as skills grow.
Your genes may have an impact on how drugs work for you
Medicines used in Joubert syndrome 14 can work differently based on gene changes that affect how the body processes drugs or how brain cells respond. Pharmacogenetic testing and cautious dose‑finding help clinicians choose safer, more effective options for each person.
Pharmacological treatments
Medicines for Joubert syndrome 14 focus on easing day-to-day symptoms and protecting organs that can be affected, like the kidneys and liver. There’s no single drug that treats the underlying condition, so treatment plans are personalized and may change over time. Not everyone responds to the same medication in the same way. Some medicines may also help with early symptoms of Joubert syndrome 14, such as reflux, sleep disruption, or irregular breathing in infancy.
Levetiracetam can reduce seizure frequency for people with Joubert syndrome 14 who develop epilepsy. It is generally well tolerated and does not require blood-level monitoring.
Enalapril (an ACE inhibitor) helps control high blood pressure and reduce protein loss in urine when the kidneys are involved. Lower pressure and less protein leakage can slow kidney damage over time.
Ursodiol (ursodeoxycholic acid) can improve bile flow when the liver is affected. This may ease itching and support liver tests, especially in cholestasis or early scarring.
Cholestyramine can lessen bile-related itching in liver involvement. Rifampin is another option if itching persists despite first steps.
Genetic influences
Joubert syndrome 14 often occurs when a child inherits two non-working copies of the same gene—one from each parent; this pattern is called autosomal recessive inheritance. In this pattern, parents are usually healthy carriers. With each pregnancy, there is a 25% (1 in 4) chance of an affected child, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance the child will inherit neither change. A “carrier” means you hold the gene change but may not show symptoms. The gene involved helps cells coordinate early brain and organ development, so the features of Joubert syndrome 14 can differ in type and severity from one person—or one sibling—to another. Genetic testing for Joubert syndrome 14, along with genetic counseling, can confirm the specific gene change and help families understand risks and options for future planning and monitoring.
Is Joubert syndrome 14 genetic?
Genetics are central to Joubert syndrome 14. It is typically caused by inherited changes in the TTC21B gene, affecting cilia function. Most cases follow an autosomal recessive pattern; carrier testing and genetic counseling can guide family planning and recurrence risk.
Pharmacogenetics—how genetics influence drug effects
A confirmed genetic diagnosis can shape everyday care, even though there isn’t a single medicine that directly treats Joubert syndrome 14. It alerts your care team to possible kidney, liver, eye, and breathing issues, which in turn influences which drugs are chosen, the starting dose, and how closely you’re monitored. Beyond trial and error, genetics offers another way to match certain medicines and doses to the individual. Pharmacogenetic testing in Joubert syndrome 14 doesn’t tell how severe the condition will be, but it can sometimes predict how you process common symptom‑control medicines like seizure drugs, antidepressants, or some pain relievers. The gene changes that cause the syndrome don’t usually affect the enzymes that break down medicine; instead, any useful pharmacogenetic results come from separate drug‑metabolism genes, while the Joubert diagnosis guides organ‑based precautions. For example, if kidney function is reduced, doses may need adjustment, and if breathing control is affected, sedatives and opioids are used with extra caution—combining this clinical picture with any pharmacogenetic results helps your team choose safer options.
Interactions with other conditions
Day to day, colds or chest infections can make irregular breathing and low muscle tone worse, so therapies, feeding, and sleep may feel harder for a while. Doctors call it a “comorbidity” when two conditions occur together. Many people with Joubert syndrome 14 also develop kidney problems (often called nephronophthisis) or liver scarring, and these can change how medicines are cleared and increase the need to prevent dehydration during illness. Eye conditions like retinal dystrophy may overlap, which can compound balance and coordination issues that are early symptoms of Joubert syndrome 14. Because Joubert syndrome 14 belongs to a group of “ciliopathy” disorders, it biologically overlaps with other conditions that affect the same tiny cell structures, so brain, kidney, eye, and liver findings can cluster in the same person. If seizures, sleep apnea, or autism traits are present, they can interact with movement and learning challenges; sedating seizure medicines or poorly controlled seizures may reduce alertness or slow breathing, and untreated sleep apnea can add daytime fatigue.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, families described babies who were floppy at birth, took longer to sit or crawl, and later walked with an unsteady, swaying gait. Parents noticed the wide, “searching” eye movements and brief pauses in breathing during sleep. Doctors, working from these everyday clues, grouped these patterns long before the full picture of Joubert syndrome 14 emerged.
First described in the medical literature as a brain development disorder with a distinctive “molar tooth sign” on MRI, the broader Joubert spectrum was initially pieced together from careful bedside observation. Over time, descriptions became more precise as imaging showed the underdevelopment of structures that coordinate balance, eye movements, and breathing. What began as notes about low muscle tone and delayed milestones grew into a recognizable set of features that linked far-flung cases.
In recent decades, knowledge has built on a long tradition of observation. As genetic tools became more widely available, researchers learned that Joubert syndromes are not a single condition but a group caused by changes in different genes involved in tiny cell structures called cilia. One of these genes, TMEM237, came to define Joubert syndrome 14. This naming reflects the order of gene discovery, not severity, and helped explain why some people had mainly movement and breathing issues while others also had kidney, liver, or eye involvement.
Generations of similar symptoms within families had hinted at inheritance, and genetic studies confirmed that many forms, including Joubert syndrome 14, are usually passed down in an autosomal recessive pattern. That means parents who feel healthy can both carry a silent change in the same gene and have a child who shows features of the condition. Identifying the gene made genetic counseling and carrier testing possible for relatives who wanted it.
As medical science evolved, newborn care improved, MRIs became standard, and early therapies expanded. This changed day-to-day life for many living with Joubert syndrome 14, with earlier recognition of low muscle tone, tailored physical and occupational therapy, and closer checks for kidney or eye changes. Meanwhile, registries and international collaborations connected families and clinicians, refining the understanding of how varied the condition can be from one person to another.
Despite evolving definitions, the thread through the history of Joubert syndrome 14 is consistent: careful observation leading to clearer diagnosis, then genetics adding depth and certainty. This path—from bedside notes to brain imaging to gene discovery—shaped today’s approach, where a child’s early symptoms prompt timely testing and coordinated care, and where families can plan with better information than ever before.